Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Banned Mandrax worth...

    Banned Mandrax worth Rs 3000 Crore seized, Bollywood Producer Arrested

    Written by savita thakur thakur Published On 2016-11-02T14:59:28+05:30  |  Updated On 2 Nov 2016 2:59 PM IST
    Banned Mandrax worth Rs 3000 Crore seized, Bollywood Producer Arrested

    New Delhi : In its biggest-ever drug seizure, the Directorate of Revenue Intelligence (DRI) has seized a huge haul of banned narcotic substance worth over Rs 3,000 crore from a factory in Udaipur and also arrested Bollywood producer Subash Dudhani in this connection.


    DRI officials raided the premises of Udaipur-based Marudhar Drinks and detected a room filled with cartons of banned Mandrax tablets.


    Methaqualone or
    Mandrax is a sedative and hypnotic medication.

    "The total number of tablets are estimated to be about 2 crore in numbers with a weight of about 23.5 metric tonnes.

    The international market value of seized tablets is estimated to be over Rs 3,000 crore," CBEC chairperson Najib Shah said.


    This is the biggest ever drug seizure done by DRI, the investigative arm of the Central Board of Excise and Customs (CBEC).


    "We have arrested the mastermind and efforts are underway to nab others involved with the drug syndicate," he said.


    Shah said that Subhas Dudhani, who has produced Bollywood films, also had businesses and properties in Mumbai.


    The information came to DRI Mumbai and then it was traced to Udaipur and with active assistance from Border Security Force (BSF), the mastermind was arrested.


    The drug is commonly known as Mandrax, M-Pills, buttons or smarties and is usually smoked mixed with cannabis. It is used as a recreational drug in Africa and Asia.


    "The consignment was manufactured in Rajasthan and consigned for Mozambique or South Africa," he said.


    In last 5 years, the DRI has seized more than 540 kgs of heroin and 7,409 kgs of ephedrine along with other narcotics and psychotropic substances.


    In recent past, the DRI has also neutralised 10 other factories manufacturing synthetic drugs like Mephedrone, Ketamine, Alprazolam and Ephedrine, across several states.

    ArrestedBorder Security ForceBSFCBESCentral Board of Excise and CustomsDirectorate of Revenue IntelligenceDRIMandraxSubash Dudhani
    Source : PTI inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok